Management of intramuscular melanoma metastases to the psoas
-
Published:2024-06
Issue:6
Volume:17
Page:e257500
-
ISSN:1757-790X
-
Container-title:BMJ Case Reports
-
language:en
-
Short-container-title:BMJ Case Rep
Author:
Cash Charles Joseph,Pearson Joseph Matthew,Milikowski Clara,Feun Lynn,Ritch Chad,Möller Mecker G
Abstract
We detail a case of a woman in her 40s with isolated melanoma skeletal muscle metastasis (MSMM) to the right psoas muscle. This patient underwent R0 surgical resection through a novel pelvic approach. She received subsequent adjuvant immunotherapy with Braftovi/Mektov along with adjuvant radiation. She is currently disease free at 9 months post surgery. Here, we describe our novel surgical approach including description of the tumour pathology. We explain our multidisciplinary management of MSMM consisting of a multidisciplinary surgical approach by surgical oncology, gynecological oncology and urology as well as multidisciplinary medical management by oncology, radiation oncology and pathology. Finally, we discuss best current options for therapeutic management.
Reference21 articles.
1. Epidemiology of non-Hodgkin's lymphoma;Thandra;Med Sci (Basel),2021
2. Increasing Burden of Melanoma in the United States
3. Heistein JB , Acharya U , Mukkamalla SKR . Malignant Melanoma. Treasure Island (FL): StatPearls, 2022.
4. Cancer Statistics, 2009
5. Metastatic malignant Melanoma;Meric;Drugs Today (Barc),2003